Benjamin Edwards Inc. Trims Position in Merck & Co., Inc. $MRK

Benjamin Edwards Inc. reduced its stake in Merck & Co., Inc. by 4.3% in the fourth quarter of the prior year, selling over 21,000 shares. Despite this trim, Merck exceeded Q1 expectations with strong revenue and adjusted EPS, and provided positive FY-2026 guidance. Institutional investors hold a significant portion of Merck’s stock, while insider selling has also occurred recently.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin